Perfusion Medical
- Biotech or pharma, therapeutic R&D
Perfusion Medical is developing PM-208, a novel IV therapeutic designed to rapidly re-establish blood flow through tissue capillaries to resolve ischemia and enhance organ perfusion. To date, PM-208 has been supported with $19 million in Department of Defense funding.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}